Order:
  1.  57
    Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era.Don Chalmers, Dianne Nicol, Jane Kaye, Jessica Bell, Alastair V. Campbell, Calvin W. L. Ho, Kazuto Kato, Jusaku Minari, Chih-Hsing Ho, Colin Mitchell, Fruzsina Molnár-Gábor, Margaret Otlowski, Daniel Thiel, Stephanie M. Fullerton & Tess Whitton - 2016 - BMC Medical Ethics 17 (1):1.
    _BMC Medical Ethics_ is an open access journal publishing original peer-reviewed research articles in relation to the ethical aspects of biomedical research and clinical practice, including professional choices and conduct, medical technologies, healthcare systems and health policies. _BMC __Medical Ethics _is part of the _BMC_ series which publishes subject-specific journals focused on the needs of individual research communities across all areas of biology and medicine. We do not make editorial decisions on the basis of the interest of a study or (...)
    Direct download (8 more)  
    Translate
     
     
    Export citation  
     
    Bookmark   7 citations  
  2.  15
    A Role for Research Ethics Committees in Exchanges of Human Biospecimens Through Material Transfer Agreements.Donald Chalmers, Dianne Nicol, Pilar Nicolás & Nikolajs Zeps - 2014 - Journal of Bioethical Inquiry 11 (3):301-306.
    International transfers of human biological material (biospecimens) and data are increasing, and commentators are starting to raise concerns about how donor wishes are protected in such circumstances. These exchanges are generally made under contractual material transfer agreements (MTAs). This paper asks what role, if any, should research ethics committees (RECs) play in ensuring legal and ethical conduct in such exchanges. It is recommended that RECs should play a more active role in the future development of best practice MTAs involving exchange (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  3.  3
    Mitochondrial Donation: The Australian Story.Dianne Nicol & Bernadette Richards - 2020 - Journal of Bioethical Inquiry 17 (2):161-164.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  4.  23
    Genomics in Research and Health Care with Aboriginal and Torres Strait Islander Peoples.Rebekah McWhirter, Dianne Nicol & Julian Savulescu - 2015 - Monash Bioethics Review 33 (2-3):203-209.
    Genomics is increasingly becoming an integral component of health research and clinical care. The perceived difficulties associated with genetic research involving Aboriginal and Torres Strait Islander people mean that they have largely been excluded as research participants. This limits the applicability of research findings for Aboriginal and Torres Strait Islander patients. Emergent use of genomic technologies and personalised medicine therefore risk contributing to an increase in existing health disparities unless urgent action is taken. To allow the potential benefits of genomics (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  5. Cross-Cultural Biotechnology: A Reader.Stella Gonzalez Arnal, Donald Chalmers, David Kum-Wah Chan, Margaret Coffey, Jo Ann T. Croom, Mylène Deschênes, Henrich Ganthaler, Yuri Gariev, Ryuichi Ida, Jeffrey P. Kahn, Martin O. Makinde, Anna C. Mastroianni, Katharine R. Meacham, Bushra Mirza, Michael J. Morgan, Dianne Nicol, Edward Reichman, Susan E. Wallace & Larissa P. Zhiganova (eds.) - 2004 - Rowman & Littlefield Publishers.
    This book is a rich blend of analyses by leading experts from various cultures and disciplines. A compact introduction to a complex field, it illustrates biotechnology's profound impact upon the environment and society. Moreover, it underscores the vital relevance of cultural values. This book empowers readers to more critically assess biotechnology's value and effectiveness within both specific cultural and global contexts.
     
    Export citation  
     
    Bookmark   1 citation  
  6.  13
    Balancing Access to Pharmaceuticals with Patent Rights.Dianne Nicol - 2003 - Monash Bioethics Review 22 (2):50-62.
    It is generally recognised that public health problems in the developing world are dire and that the rest of the world has a moral commitment to provide assistance. Yet many of the world’s poor are unable to access essential pharmaceuticals simply because products that are under patent are too expensive and cheaper generics are not available. One of the proposed solutions to this problem is to allow domestic manufacture of generic products in response to public health crises. However, this solution (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark